Amy Schacterle

Chief Operating Officer at SAGE THERAPEUTICS, INC.

Health Technology

Consumer Services

Profile

Presently, Amy Schacterle occupies the position of Senior VP-Research & Development Strategy at SAGE Therapeutics, Inc. In her past career Dr. Schacterle was Vice President-Regulatory Affairs at Sunovion Pharmaceuticals, Inc. She received an undergraduate degree from Rensselaer Polytechnic Institute and a doctorate and a graduate degree from the University of Virginia.

Amy Schacterle active positions

Companies	Position	Start
SAGE THERAPEUTICS, INC.	Chief Operating Officer	2020-03-31

All active positions of Amy Schacterle

Former positions of Amy Schacterle

Companies	Position	End
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.	General Counsel	2013-12-31

See the detail of Amy Schacterle's experience

Training of Amy Schacterle

University of Virginia	Doctorate Degree
Rensselaer Polytechnic Institute	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Amy Schacterle's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
SAGE THERAPEUTICS, INC.	Health Technology

Private companies	1
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.	Health Technology